Drug

ABX-1431 clinical trials

Also written ABX-1431.

studies test it: 15
open now: 0
in phase 3: 0
first study started: 2016

How studies write it

Studies that test it under each name

Name

Lu AG06466: 9

Development codes

ABX-1431: 6

Studies by the year they started

15 studies that test it; most in 2020 (4)

Studies that test ABX-1431, by start year
Year	Studies
2016	2
2017	3
2018	1
2020	4
2021	4
2022	1

By phase

A phase 1/2 study counts in both.

Phase 1: 14
Phase 2: 1

What it is tested for

Each study’s main condition, where its own words name it.

Tourette Syndrome: 2
Peripheral Nervous System Diseases: 1
Neuromyelitis Optica: 1
Hyperalgesia: 1
Multiple Sclerosis: 1
Epilepsies, Partial: 1
Fibromyalgia: 1
Dyspepsia: 1

Who runs them

Industry 15 · Other 0

H. Lundbeck A/S (9) · Abide Therapeutics (6)

Studies

Open first, then newest update. How each study uses ABX-1431 is read from its arms, and is right about nine times in ten.

Testing it · 15

Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD)CompletedPhase 1H. Lundbeck A/SNCT04597450Written as Lu AG06466
A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple SclerosisTerminatedPhase 1H. Lundbeck A/SNCT04990219Written as Lu AG06466
A Study of Lu AG06466 in Participants With Treatment Resistant Focal EpilepsyTerminatedPhase 1H. Lundbeck A/SNCT05081518Written as Lu AG06466
Binding and Effects of Lu AG06466 in the Brain of Healthy MenCompletedPhase 1H. Lundbeck A/SNCT05219838Written as Lu AG06466
Safety and Tolerability Study of Lu AG06466 in Healthy Young Japanese and Caucasian ParticipantsTerminatedPhase 1H. Lundbeck A/SNCT05177029Written as Lu AG06466
A Study to Evaluate Lu AG06466 in Participants With FibromyalgiaTerminatedPhase 1H. Lundbeck A/SNCT04974359Written as Lu AG06466
Drug Drug Interaction Study With Lu AG06466 in Young Healthy MenCompletedPhase 1H. Lundbeck A/SNCT04713254Written as Lu AG06466
Binding of Lu AG06466 in the Brain in Healthy MenCompletedPhase 1H. Lundbeck A/SNCT04419636Written as Lu AG06466
Study That Evaluates the Effect of CYP3A4 Inhibition on Lu AG06466 in Healthy Men and WomenCompletedPhase 1H. Lundbeck A/SNCT04405323Written as Lu AG06466
Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic DisorderCompletedPhase 2Abide TherapeuticsNCT03625453Written as ABX-1431
Titration Study of ABX-1431CompletedPhase 1Abide TherapeuticsNCT03447756Written as ABX-1431
Central Pain Study for ABX-1431CompletedPhase 1Abide TherapeuticsNCT03138421Written as ABX-1431 HCl
An fMRI Study in Healthy Volunteers to Investigate the Effects of ABX-1431 on Experimental Hyperalgesia and Its Neural CorrelatesCompletedPhase 1Abide TherapeuticsNCT02929264Written as ABX-1431
A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette SyndromeCompletedPhase 1Abide TherapeuticsNCT03058562Written as ABX-1431
A Study to Evaluate the Effects of ABX-1431 on Patients With Functional DyspepsiaTerminatedPhase 1Abide TherapeuticsNCT02875678Written as ABX-1431